Filing Details

Accession Number:
0001447362-20-000159
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2020-07-28 16:48:57
Reporting Period:
2020-07-16
Accepted Time:
2020-07-28 16:48:57
Original Submission Date:
2020-07-28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1447362 Castle Biosciences Inc CSTL Services-Medical Laboratories (8071) 770701774
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1588970 H Bonnie Anderson C/O Castle Biosciences
820 S. Friendswood Drive, Suite 201
Friendswood TX 77546
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-07-16 1,228 $42.90 23,495 No 4 S Indirect By trust
Common Stock Disposition 2020-07-16 1,763 $44.00 21,732 No 4 S Indirect By trust
Common Stock Disposition 2020-07-16 9 $45.06 21,723 No 4 S Indirect By trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By trust
No 4 S Indirect By trust
No 4 S Indirect By trust
Footnotes
  1. The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on March 17, 2020.
  2. This transaction was executed in multiple trades at prices ranging from $42.51 to $43.14, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. Held by the Bonnie H. Anderson Living Trust, or the Anderson Trust. The Reporting Person is the trustee of the Anderson Trust.
  4. This transaction was executed in multiple trades at prices ranging from $43.61 to $44.52, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.